EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial

Emilie Le Rhun, Thierry Gorlia, Jörg Felsberg, Joost Jongen, Claude-Alain Maurage, François Ducray, Dorothee Gramatzki, Peter Hau, Olivier L Chinot, Matthias Preusser, Stephanie Cartalat, Patrick Roth und 5 weitere

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2023.113475 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Emilie Le Rhun und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; Department of Neurology,…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Heterocyclic Compounds, 4 or More Rings. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHeterocyclic Compounds, 4 or More RingsHumansAgedTemozolomideDacarbazineMyeloid Cell Leukemia Sequence 1 ProteinNeoplasm Recurrence, LocalEnzyme InhibitorsAntineoplastic Agents, Alkylating

Stichwörter der Autor:innen

AstrocytomaC-MYCCDKChemotherapySurvival proteins

Substanzen

Temozolomide14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decae…DacarbazineMyeloid Cell Leukemia Sequence 1 ProteinEnzyme InhibitorsAntineoplastic Agents, AlkylatingHeterocyclic Compounds, 4 or More Rings

Autor:innen und Institutionen

  • Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Z…
  • European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
  • The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Univ. Lille, UFR3S - Laboratoire d'Histologie, Lille, France.
  • CHU Lyon, Neuro-Oncology, Lyon, France.

Zitieren

APA

Le Rhun, E., Gorlia, T., Felsberg, J., Jongen, J., Maurage, C. A., Ducray, F., Gramatzki, D., Hau, P., Chinot, O. L., Preusser, M., Cartalat, S., Roth, P., van den Bent, M., Furtner, J., Collienne, M., Reifenberger, G., & Weller, M. (2024). Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113475

Vancouver

Le Rhun E, Gorlia T, Felsberg J, Jongen J, Maurage CA, Ducray F, et al. Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2023.113475

BibTeX
@article{LeRhun2024,
  author = {Le Rhun, Emilie and Gorlia, Thierry and Felsberg, Jörg and Jongen, Joost and Maurage, Claude-Alain and Ducray, François and Gramatzki, Dorothee and Hau, Peter and Chinot, Olivier L and Preusser, Matthias and Cartalat, Stephanie and Roth, Patrick and van den Bent, Martin and Furtner, Julia and Collienne, Maike and Reifenberger, Guido and Weller, Michael},
  title = {Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2023.113475}
}
Kostenlos starten →